Bnp Paribas Asset Management Holding S.A. Arcus Biosciences, Inc. Transaction History

Bnp Paribas Asset Management Holding S.A.

$38.6 Billion
Q3 2025

A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 1,419,985 shares of RCUS stock, worth $28.5 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,419,985

Previous 1,395,726 1.74%

Holding current value

$28.5 Million

Previous $11.4 Million 69.97%

% of portfolio

0.05%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$8.22 - $13.6 $199,408 - $329,922	24,259 Added 1.74%	1,419,985 $19.3 Million
Q2 2025 Aug 05, 2025	SELL	$6.87 - $10.03 $1.6 Million - $2.33 Million	-232,293 Reduced 14.27%	1,395,726 $11.4 Million
Q1 2025 May 13, 2025	BUY	$7.85 - $15.24 $833,944 - $1.62 Million	106,235 Added 6.98%	1,628,019 $12.8 Million
Q4 2024 Feb 11, 2025	BUY	$14.28 - $18.44 $8.44 Million - $10.9 Million	590,736 Added 63.45%	1,521,784 $22.7 Million
Q3 2024 Nov 08, 2024	BUY	$13.69 - $18.01 $2.56 Million - $3.36 Million	186,750 Added 25.09%	931,048 $14.2 Million

Q2 2024 Jul 29, 2024	BUY	$14.59 - $18.48 $864,793 - $1.1 Million	59,273 Added 8.65%	744,298 $11.3 Million
Q1 2024 May 08, 2024	BUY	$14.83 - $20.18 $2.15 Million - $2.93 Million	145,298 Added 26.92%	685,025 $12.9 Million
Q4 2023 Feb 09, 2024	BUY	$13.43 - $19.63 $307,050 - $448,800	22,863 Added 4.42%	539,727 $10.3 Million
Q3 2023 Nov 13, 2023	SELL	$17.62 - $23.54 $1.66 Million - $2.22 Million	-94,308 Reduced 15.43%	516,864 $9.28 Million
Q2 2023 Aug 08, 2023	SELL	$16.97 - $22.03 $2.78 Million - $3.6 Million	-163,620 Reduced 21.12%	611,172 $12.4 Million
Q1 2023 May 08, 2023	BUY	$15.96 - $23.15 $147,502 - $213,952	9,242 Added 1.21%	774,792 $14.1 Million
Q4 2022 Feb 09, 2023	BUY	$19.7 - $35.71 $2.82 Million - $5.11 Million	142,986 Added 22.97%	765,550 $15.8 Million
Q3 2022 Nov 10, 2022	BUY	$23.23 - $30.07 $1.49 Million - $1.92 Million	63,962 Added 11.45%	622,564 $16.3 Million
Q2 2022 Aug 04, 2022	SELL	$17.23 - $37.73 $4.11 Million - $9 Million	-238,489 Reduced 29.92%	558,602 $14.2 Million
Q1 2022 May 12, 2022	SELL	$28.92 - $41.83 $1.86 Million - $2.69 Million	-64,203 Reduced 7.45%	797,091 $25.2 Million
Q4 2021 Feb 09, 2022	BUY	$31.38 - $48.47 $2.39 Million - $3.69 Million	76,188 Added 9.7%	861,294 $34.9 Million
Q3 2021 Nov 08, 2021	BUY	$26.93 - $37.68 $12.7 Million - $17.8 Million	473,310 Added 151.8%	785,106 $27.4 Million
Q2 2021 Aug 05, 2021	BUY	$22.75 - $35.77 $7.09 Million - $11.2 Million	311,796 New	311,796 $8.56 Million

Others Institutions Holding RCUS

# of Institutions

212

Shares Held

67.7M

Call Options Held

3.3M

Put Options Held

146K

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.45B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.

Account

Bnp Paribas Asset Management Holding S.A. Arcus Biosciences, Inc. Transaction History